HM15211 vs Oxyntomodulin

Head-to-head comparison of HM15211 (HM15211, glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide/glucagon receptor triagonist) and Oxyntomodulin (Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyHM15211Oxyntomodulin
CategoryWeight ManagementWeight Management
Full NameHM15211, glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide/glucagon receptor triagonistEndogenous glucagon-like peptide 1 and glucagon co-agonist peptide
Molecular WeightN/A~4,200 Da
Half-LifeApproximately 1 week12-15 minutes
Amino AcidsN/A37
Typical DoseInvestigational; no established human doseResearch doses vary; commonly 100-300 mcg in small human studies
RouteSubcutaneousSubcutaneous/IV
Purity≥98%≥98%
Studies Count1280
Research StatusClinicalClinical

HM15211 Benefits

  • appetite suppression
  • greater fat oxidation
  • weight loss
  • improved metabolic markers

Oxyntomodulin Benefits

  • reduces appetite
  • increases satiety
  • supports weight loss
  • improves postprandial metabolic signaling

HM15211 Dosing

once-weekly subcutaneous injection|titration to effect|maintenance at tolerated dose

Oxyntomodulin Dosing

Research-only dosing|Subcutaneous or IV administration in trials|Pair with calorie restriction and monitoring

HM15211 Side Effects

  • nausea
  • vomiting
  • reduced appetite

Oxyntomodulin Side Effects

  • nausea
  • GI discomfort
  • decreased appetite beyond target

Research Overview

HM15211

Research has shown potent weight-reducing and metabolic effects in preclinical and translational studies. The compound is being developed as a next-generation incretin-based therapy.

Oxyntomodulin

Human studies showed acute reductions in food intake and modest weight loss, helping establish the GLP-1 and glucagon co-agonism concept. It remains a foundational peptide for obesity and satiety research.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

HM15211 stacks with:

metformintopiramate

Oxyntomodulin stacks with:

calorie-deficitresistance-training
glp1gipglucagontriagonistobesityGLP-1glucagon-coagonistendogenous-peptideappetite-regulation